Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs. Connecting patients directly to medical research and incentivizing them to share their data with tokens, blockchain is the decentralized technology everyone was waiting for to move away from the current linear process of drug approvals, to a new iterative model where trustworthy digital health data is shared in real time between patients, life sciences and regulators. The 21st Century Cures Act (2016) gave the FDA a mandate to accelerate approvals if more patient real world data was shared proactively by pharma. Embleema’s blockchain speeds up this process with patient buy-in, accelerating time to market new drugs.
We believe Blockchain technology is the ideal standard that can provide patients, healthcare professionals, health insurance payers and providers a shared, comprehensive, longitudinal, and trusted view of a patient’s medical history. When preserved as a ledger of transactions, a patient’s medical history is clearly accessible to all stakeholders with due authorization from the patient, and the best treatment option can be determined.
PatientTruth™ is a Cloud and Blockchain-based software solution that connects to a patient’s different medical records at the various centers of healthcare services, such as hospitals, primary care practices, rehabilitative centers, nursing homes and urgent care centers, and chains them into a consistent, comprehensive, and tamper-proof medical history. PatientTruth™ provides a holistic view of a patient’s medical history across providers and care centers.